The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Abstract
Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ang II binds the ATR1 (Ang II receptor 1) receptor leading to release of TNF α and IL-6, 55 which is associated with hypertension, diabetes, and heart disease 52,56,57 -major comorbidities in severe COVID-19.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [52]
In the citing paper
“ACE2 not only functions as a viral receptor for SARSCoV-2 but also regulates blood pressure.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [52]
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citationGlobal Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 786
Cited by
Sorted by citations
Items 901–999 of 999
Ferrario, C. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000060688.57053.7e · Cited by 24
Self-citationSpeculation is not evidence: antihypertensive therapy and COVID-19
SIMONE, G. D., & Mancusi, C. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa021 · Cited by 23
Prehypertension: Underlying pathology and therapeutic options
Albarwani, S. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.728 · Cited by 24
Li, S., Wang, Z. K., Yang, X., Hu, B., Huang, Y., & Sujing, F. (2017) · Peptides · doi:10.1016/j.peptides.2017.02.007 · Cited by 23
Renin–angiotensin system blockade in the COVID-19 pandemic
Cohen, J. B., South, A. M., Shaltout, H. A., Sinclair, M. R., & Sparks, M. A. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab026 · Cited by 23
Farkas, C., Mella, A., Turgeon, M., & Haigh, J. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.665041 · Cited by 26
Lineage-specific positive selection on ACE2 contributes to the genetic susceptibility of COVID-19
Pan, Y., Liu, P., Wang, F., Wu, P., Cheng, F., Jin, X., & Xu, S. (2022) · National Science Review · doi:10.1093/nsr/nwac118 · Cited by 21
Angiotensin-(1–9) in hypertension
Norambuena‐Soto, I., López‐Crisosto, C., Martinez-Bilbao, J., Hernández-Fuentes, C. P., Parra, V., Lavandero, S., & Chiong, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115183 · Cited by 27
Chan, K., Farias, A. G., Lee, H., Guvenc, F., Mero, P., Brown, K. R., Ward, H. N., Billmann, M., Aulakh, K., Astori, A., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12744 · Cited by 27
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Eiring, P., Klein, T., Backes, S., Streit, M., Jungblut, M., Doose, S., Beliu, G., & Sauer, M. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300821 · Cited by 23
Shao, Z., Shrestha, K. L., Borowski, A. G., Kennedy, D. J., Epelman, S., Thomas, J. D., & Tang, W. H. W. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.06.296 · Cited by 23
Xiao, H., Fuchs, S., Bernstein, E. A., Li, P., Campbell, D. J., & Bernstein, K. E. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01147.2007 · Cited by 23
Byku, M., Macarthur, H., & Westfall, T. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00400.2009 · Cited by 23
Li, W., Wang, R., Ma, J., Wang, M., Cui, J., Wu, W., Liu, R.-M., Zhang, C., Li, W., & Wang, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481756 · Cited by 23
Akhabue, E., Vu, T. T., Vaidya, A., Michos, E. D., de Boer, I. H., Kestenbaum, B. R., Allison, M., Szklo, M., Ouyang, P., Yancy, C. W., et al. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy142 · Cited by 23
Nie, L., Dai, K., Wu, J., Zhou, X., Hu, J., Zhang, C., Zhan, Y., Song, Y., Fan, W., Hu, Z., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13710 · Cited by 23
Structural diversity of angiotensin‐converting enzyme
Bingham, R. J., Dive, V., Phillips, S. E. V., Shirras, A. D., & Isaac, R. E. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05069.x · Cited by 23
Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides
Liang, G., Li, Y., Kang, L., Hu, M. Y., & Li, Z. (2008) · Amino Acids · doi:10.1007/s00726-008-0177-8 · Cited by 23
Sex differences in response to chronic heart failure therapies
Ghali, J. K., & Lindenfeld, J. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.555 · Cited by 22
Targeting genes in the renin–angiotensin system
Le, T. H., & Coffman, T. M. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f2fd39 · Cited by 23
The Discovery of the ACE2 Gene
Marian, A. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.301271 · Cited by 22
COVID-19 Infection in the Human Reproductive Tract of Men and Nonpregnant Women
Morelli, F., Meirelles, L. E. D. F., de Souza, M. V. F., Mari, N. L., Mesquita, C. S. S., Dartibale, C. B., Damke, G. M. Z. F., Damke, E., da Silva, V. R. S., Souza, R. P., et al. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-1098 · Cited by 22
Hosseini, P., Afzali, S., Karimi, M., Zandi, M., Zebardast, A., Latifi, T., Tabibzadeh, A., Ramezani, A., Zakeri, A., Zakeri, A., et al. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000267 · Cited by 22
Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury
Lidberg, K. A., Muthusamy, S., Adil, M., Mahadeo, A., Yang, J., Patel, R. S., Wang, L., Bammler, T. K., Reichel, J. B., Yeung, C. K., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060751 · Cited by 22
Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19
Li, S., Wang, J., Yan, Y., Zhang, Z., Gong, W., & Nie, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.862571 · Cited by 22
Warner, F. J., Guy, J. L., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442567 · Cited by 22
Baharin, A., Ting, T., & Goh, H. (2022) · Plants · doi:10.3390/plants11101330 · Cited by 22
Vitamin C promotes ACE2 degradation and protects against SARS‐CoV‐2 infection
Zuo, Y., Zheng, Z., Huang, Y., He, J., Zang, L., Ren, T., Cao, X., Miao, Y., Yuan, Y., Liu, Y., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256374 · Cited by 22
Kunvariya, A. D., Dave, S. A., Modi, Z. J., Patel, P. K., & Sagar, S. R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15644 · Cited by 21
Mello, W. C. D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00072 · Cited by 22
Increased hypothalamic angiotensin-(1–7) levels in rats with aortic coarctation-induced hypertension
Gironacci, M. M., Brosnihan, K. B., Ferrario, C. M., Gorzalczany, S. B., Verrilli, M. A. L., Pascual, M. M., Taira, C. A., & Peña, C. (2007) · Peptides · doi:10.1016/j.peptides.2007.06.016 · Cited by 22
Self-citationZhang, W., Miao, J., Li, P., Wang, Y., & Zhang, Y. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.01.028 · Cited by 22
The Renin Angiotensin System and the Metabolic Syndrome~!2010-02-12~!2010-04-19~!2010-06-25~!
Wang, C.-H., Li, F., & Takahashi, N. (2010) · The Open Hypertension Journal · doi:10.2174/1876526201003010001 · Cited by 22
Clarke, C., Flores‐Muñoz, M., McKinney, C. A., Milligan, G., & Nicklin, S. A. (2012) · Future Cardiology · doi:10.2217/fca.12.75 · Cited by 21
Liao, F.-T., Chang, C.-Y., Su, M., & Kuo, W. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.1.011014 · Cited by 22
Nyimanu, D., Kay, R. G., Šulentić, P., Kuc, R. E., Ambery, P., Jermutus, L., Reimann, F. M., Gribble, F. M., Cheriyan, J., Maguire, J. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56157-9 · Cited by 22
A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
Prestes, P. R., Maier, M. C., Woods, B. A., & Charchar, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103666 · Cited by 23
SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review
Deravi, N., Fathi, M., Vakili, K. G., Yaghoobpoor, S., Pirzadeh, M., Mokhtari, M., Fazel, T., Ahsan, E., & Ghaffari, S. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.03.78 · Cited by 21
González, S. M., Siddik, A. B., & Su, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612807 · Cited by 23
Harrison, D. G., & Luther, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00006-9 · Cited by 21
COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis
Ramachandran, P., Kathirvelu, B., Chakraborti, A., Gajendran, M., Zahid, U., Ghanta, S., Onukogu, I., Narh, J. T., Wang, J. C. C., & Anwer, F. (2020) · Cancer Control · doi:10.1177/1073274820960457 · Cited by 21
Translating bioactive peptides for COVID-19 therapy
Bhullar, K. S., Drews, S. J., & Wu, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173661 · Cited by 21
Cyclic 68 Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2
Parker, M. F. L., Blecha, J. E., Rosenberg, O. S., Ohliger, M. A., Flavell, R. R., & Wilson, D. M. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.261768 · Cited by 23
Saih, A., Baba, H., Bouqdayr, M., Ghazal, H., Hamdi, S., Kettani, A., & Wakrim, L. (2021) · BioMed Research International · doi:10.1155/2021/6685840 · Cited by 21
Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu, Y., Liu, L., & Lu, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725967 · Cited by 22
Shukla, P., Chopada, K., Sakure, A. A., & Hati, S. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220106100225 · Cited by 21
Williams, T., Strachan, G., Macrae, R. G. C., Kuc, R. E., Nyimanu, D., Paterson, A., Sinha, S., Maguire, J. J., & Davenport, A. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-03731-9 · Cited by 26
Immune system changes in those with hypertension when infected with SARS-CoV-2
Su, S., Chen, R., Zhang, S., Shu, H., & Luo, J. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104562 · Cited by 23
Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
Egan, B. M., Scharf, A., Pohl, F., & Kornfeld, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.938650 · Cited by 21
Giani, J. F., Miquet, J. G., Muñoz, M. C., Burghi, V., Toblli, J. E., Masternak, M. M., Kopchick, J. J., Bartke, A., Turyn, D., & Dominici, F. P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.08.003 · Cited by 21
Small but powerful: Short peptide hormones and their role in autoimmune inflammation
Lühder, F., Lee, D. H., Gold, R., Stegbauer, J., & Linker, R. A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.008 · Cited by 21
Soares, D. D. S., Pinto, G. H., Lopes, A. G., Caetano, D. S. L., Nascimento, T. G., Andrades, M. É., Clausell, N., Rohde, L. E. P., Leitão, S. A. T., & Biolo, A. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00205.2018 · Cited by 21
Jacques Benoit Lecture: The Neuroendocrine View of the Angiotensin and Apelin Systems
Llorens‐Cortés, C., & Kordon, C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01642.x · Cited by 21
Ji, K., Minakawa, M., Fukui, K., Suzuki, Y., & Fukuda, I. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708098691 · Cited by 21
Vitamin D and the Renin-Angiotensin System
Li, Y. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10040-x · Cited by 21
Integrated gene expression profiling and linkage analysis in the rat
Petretto, E. G., Mangion, J., Pravenec, M., Hübner, N., & Aitman, T. J. (2006) · Mammalian Genome · doi:10.1007/s00335-005-0181-1 · Cited by 21
Ghosh, M. K., Kumar, S., Ganguly, K. K., Ghosh, P., Tabassum, S., Basu, B., & Basu, M. (2023) · Epigenomics · doi:10.2217/epi-2023-0052 · Cited by 22
Devaux, C. A., & Camoin-Jau, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042200 · Cited by 20
Ying, X. (2020) · Virology & Mycology · doi:10.35248/2161-0517.20.09.191 · Cited by 20
Iqubal, A., Iqubal, M. K., Hoda, F., Najmi, A. K., & Haque, S. E. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1893692 · Cited by 20
Immune response to COVID-19 in older adults
Jergović, M., Coplen, C. P., Uhrlaub, J. L., & Nikolich‐Žugich, J. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.017 · Cited by 20
Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection
Raafs, A. G., Ghossein, M. A., Brandt, Y., Henkens, M. T. H. M., Kooi, M. E., Vernooy, K., Spaanderman, M. E. A., Gerretsen, S. C., van Santen, S., Driessen, R., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003110 · Cited by 20
Li, Y. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00364 · Cited by 20
Kovarik, J. J., Kopecky, C., Antlanger, M., Domenig, O., Kaltenecker, C. C., Werzowa, J. M., Hecking, M., Mahr, S., Grömmer, M., Wallner, C., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.08.022 · Cited by 20
Sartório, C. L., Pimentel, E. B., dos Santos, R. L., Rouver, W. D. N., & Mill, J. G. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13368 · Cited by 20
Tanwar, V., Adelstein, J. M., & Wold, L. E. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa293 · Cited by 21
Muhanna, D., Arnipalli, S. R., Kumar, S. B., & Ziouzenkova, O. (2020) · Biomedicines · doi:10.3390/biomedicines8110460 · Cited by 21
Lafaurie, M., Martin‐Blondel, G., Delobel, P., Charpentier, S., Sommet, A., & Moulis, G. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12613 · Cited by 20
Biological Context Linking Hypertension and Higher Risk for COVID-19 Severity
Tavares, C. A. M., Bailey, M. A., & Girardi, A. C. C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.599729 · Cited by 21
Xu, F., Gao, J. L., Munkhsaikhan, U., Li, N., Gu, Q., Pierre, J. F., Starlard‐Davenport, A., Towbin, J. A., Cui, Y., Purevjav, E., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.582949 · Cited by 20
The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases
Zhu, H., Zhang, L., Ma, Y., Zhai, M., Xia, L., Liu, J., Yu, S., & Duan, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16239 · Cited by 20
Self-citationTemporal evolution, most influential studies and sleeping beauties of the coronavirus literature
Haghani, M., & Varamini, P. (2021) · Scientometrics · doi:10.1007/s11192-021-04036-4 · Cited by 20
Severe Acute Respiratory Syndrome Coronavirus Entry as a Target of Antiviral Therapies
Kuhn, J. H., Li, W., Radoshitzky, S. R., Choe, H., & Farzan, M. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s05.1 · Cited by 20
Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease
Wysocki, J. A., González‐Pacheco, F. R., & BATLLE, D. C. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0014-1 · Cited by 20
Aras, Ö., Messina, S. A., Shirani, J., Eckelman, W. C., & Dilsizian, V. (2007) · Current Cardiology Reports · doi:10.1007/bf02938342 · Cited by 20
Ma, C., Xin, H.-L., Jiang, X.-Y., Wang, Y.-X., & Zhang, Y.-S. (2014) · Genetics and Molecular Research · doi:10.4238/2014.april.3.5 · Cited by 20
CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2‐Deficient Mice
Nunes-Souza, V., Alenina, N. V., Qadri, F., Penninger, J. M., Santos, R. A. S., Bäder, M., & Rabelo, L. A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6487509 · Cited by 20
Self-citationPrimer: strategies for identifying genes involved in renal disease
de Borst, M. H., Benigni, A., & Remuzzi, G. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0785 · Cited by 20
Rat genetics: the next episode
Smits, B. M. G., & Cuppen, E. P. J. G. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.02.009 · Cited by 20
Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115370 · Cited by 19
Chattree, V., Singh, K., Singh, K., Goel, A., Maity, A., & Lone, A. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14259 · Cited by 19
Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways
Bayraktutan, U. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070501 · Cited by 22
Targeting the Protective Arm of the Renin-Angiotensin System: Focused on Angiotensin-(1–7)
Khajehpour, S., & Aghazadeh‐Habashi, A. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000397 · Cited by 19
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
Svilenov, H. L., Sacherl, J., Reiter, A., Wolff, L. S., Cheng, C., Stern, M., Grass, V., Feuerherd, M., Wachs, F., Simonavicius, N., et al. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105197 · Cited by 19
Malcangi, G., Inchingolo, A. D., Inchingolo, A. M., Santacroce, L., Marinelli, G., Mancini, A., Vimercati, L., Maggiore, M. E., D’Oria, M. T., Hazballa, D., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9091964 · Cited by 31
Kamilić, J., Hamming, I., Kreutz, R. H., Bolbrinker, J., Siems, W., Nassar, I., Sluimer, J. C., Walther, T., Navis, G. J., & van Goor, H. (2009) · Hypertension Research · doi:10.1038/hr.2009.191 · Cited by 19
Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts
Lin, C.-S., Pan, C., Wen, C.-H., Yang, T.-H., & Kuan, T.-C. (2010) · Peptides · doi:10.1016/j.peptides.2010.03.026 · Cited by 19
Zhu, P., Verma, A., Prasad, T., & Li, Q. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01716-4 · Cited by 19
Gupta, S., & Mitra, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10076-y · Cited by 19
Ederer, K. A., Jin, K., Bouslog, S., Wang, L., Gorman, G. S., Rowe, G. C., Abadir, P. M., Raftery, D., Moellering, D. R., Promislow, D., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113351 · Cited by 20
Fernandes, L., Fortes, Z. B., Casarini, D. E., Nigro, D., Tostes, R. C., Santos, R. A. S., & de Carvalho, M. H. C. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.12.006 · Cited by 19
Cells and gene expression programs in the adult human heartPreprint
Litviňuková, M., Talavera-López, C. N., Maatz, H., Reichart, D., Worth, C. L., Lindberg, E. L., Kanda, M., Polański, K., Fasouli, E. S., Samari, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.03.024075 · Cited by 19
Self-citationKwon, Y., Nukala, S. B., Srivastava, S., Miyamoto, H., Ismail, N. I., Rehman, J., Ong, S., Lee, W. H., & Ong, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.14.093583 · Cited by 19
Farkas, C., Mella, A., & Haigh, J. J. (2020) · medRxiv · doi:10.1101/2020.10.23.20218511 · Cited by 20
Hammoud, S. H., Wehbe, Z., Abdelhady, S., Kobeissy, F. H., Eid, A. H., & EL‐Yazbi, A. F. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000119 · Cited by 17
Pang, X. C., Zhang, H. X., Zhang, Z., Suguro, R., Cui, Y., & Zhu, Y. Z. (2020) · Molecules · doi:10.3390/molecules26010142 · Cited by 18
Zhang, Q.-Q., Chen, F., Wang, F., Di, X., Li, W., & Zhang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841435 · Cited by 18
Altman, N. L., Berning, A. A., Saxon, C. E., Adamek, K. E., Wagner, J. A., Slavov, D. B., Quaife, R. A., Gill, E. A., Minobe, W. A., Jonas, E. R., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.08.005 · Cited by 20
Zuo, X., Ren, S., Zhang, H., Tian, J., Tian, R., Han, B., Liu, H., Dong, Q., Wang, Z., Cui, Y., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03716-w · Cited by 18
Metadata
- Authors
- Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
- Affiliations
- University of Toronto (CA)
- Institute of Molecular Biotechnology (AT)
- University Health Network (CA)
- Barzilai Medical Center (IL)
- Atrium Health Wake Forest Baptist (US)
- Corresponding author
- Penninger, Josef M.
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6891
- Pages
- 822-828
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2025672718
- Cited by
- 1,733
- References
- 44
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
- FWCI
- 38.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Amgen
- German-Israeli Foundation for Scientific Research and Development
- Canada Research Chairs
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
- MeSH terms
- Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review